Loading organizations...
§ Venture Capital · Minneapolis, MN, USA
Investment platform managing crossover funds for healthcare and life sciences companies, leveraging Piper Sandler expertise.
Piper Heartland Healthcare Capital is a Minneapolis, Minnesota-based dedicated healthcare investment platform within Piper Sandler, managing crossover funds that target innovative healthcare companies. The platform leverages Piper Sandler's extensive expertise in healthcare investment banking, capital markets, and equity research to pursue proprietary opportunities across life sciences and other healthcare sectors. Its inaugural vehicle, Piper Heartland Healthcare Crossover Fund I, announced its final closing in March 2022, though the specific fund size was not disclosed. The firm is led by CEO and fund manager Matt Hemsley, who previously served as a Managing Director in Piper Sandler's healthcare investment banking group. Chad Abraham serves as Chairman and CEO of parent company Piper Sandler. The investment platform officially launched with the closing of its first fund in March 2022, with Matt Hemsley appointed CEO that same year.
Heartland Healthcare Capital has 2 tracked investments across 2 companies. The latest tracked deal is $220.0M Series C in Cleerly in July 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 1, 2022 | Cleerly | $220.0M Series C | Fidelity Management & Research Company, T. Rowe Price Associates | Canaan Partners, Founders Fund, Index Ventures, Morgenthaler Ventures, Presight Capital, Vensana Capital, Avid Larizadeh, Mato Peric, Peter Thiel, Breyer Capital, Cigna Ventures, DigiTx Partners, Lrvhealth, Mirae Asset Capital, Novartis, Piper Jaffray, Sands Capital |
| Nov 1, 2021 | Antios Therapeutics | $75.0M Series B | Epiq Capital Group, Craig Gordon | Domain Associates, Pontifax Venture Capital, Adage Capital Management, Aisling Capital, Altium Capital, Amzak Health, Avego Bioscience Capital, CAM Capital, Delos Capital, Granite Point Capital, GRA Venture Fund, Lifesci Venture Partners, Lumira Ventures, RA Capital Management, Sixty Degree Capital, Soleus Capital |